tegafur has been researched along with Cells, Neoplasm Circulating in 19 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixty-five patients with advanced pancreatic cancer were enrolled." | 1.46 | Clinical impact of circulating tumor cells and therapy response in pancreatic cancer. ( Arigami, T; Kijima, Y; Kurahara, H; Maemura, K; Mataki, Y; Matsushita, D; Natsugoe, S; Okubo, K; Sakoda, M; Uenosono, Y; Yanagita, S, 2017) |
| "Although gastric cancer with main portal vein tumor thrombus is a rare occurrence, its prognosis is extremely poor." | 1.43 | A long-surviving case of gastric cancer with main portal vein tumor thrombus after surgical resection and postoperative S-1 therapy. ( Kanemoto, H; Kyoden, Y; Nagai, E; Oba, N; Ohata, K; Sato, S; Suzuki, M; Takagi, M; Takahashi, M; Taki, Y; Taku, K; Watanabe, M, 2016) |
| "Gastrofiberscopy revealed that type 4 gastric cancer located at the whole gastric body." | 1.36 | [A successfully treated case of type 4 gastric cancer with intraperitoneal free cancer cells undergoing a curative resection followed by neoadjuvant chemotherapy with S-1 plus cisplatin]. ( Iwanaga, T; Iwasaki, Y; Koizumi, S; Matsumoto, H; Nakano, D; Ohashi, M; Ohinata, R; Takahashi, K; Tateishi, Y; Yamaguchi, T, 2010) |
| "A 66-year-old man was diagnosed with hepatocellular carcinoma with Vp3 by abdominal enhanced CT." | 1.35 | [A case of successful multimodal treatment for combined hepatocellular and cholangiocarcinoma with portal venous tumor thrombus]. ( Doki, Y; Eguchi, H; Hatano, H; Kobayashi, S; Marubashi, S; Mori, M; Murakami, M; Nagano, H; Takeda, Y; Tanemura, M; Tomimaru, Y; Tomokuni, A; Wakasa, K, 2009) |
| "She was diagnosed as primary gastric cancer with peritoneal dissemination and received systemic chemotherapy after distal gastrectomy for a primary lesion." | 1.34 | [A case of breast metastasis of gastric cancer]. ( Cho, H; Hasegawa, S; Kobayashi, O; Osaragi, T; Sairenji, M; Tsuburaya, A; Yoshida, T; Yoshikawa, T, 2007) |
| "A 73-year-old man with renal cell carcinoma involving the left renal vein was treated with the embolization of the left renal artery followed by interferon-alpha and UFT." | 1.30 | [Tumor reduction in advanced renal cell carcinoma with tumor thrombus by renal embolization, interferon-alpha and UFT. A case report]. ( Hamaguchi, K; Kamura, K; Matsushita, K; Seto, K; Shiomi, K; Yamauchi, T, 1997) |
| "A 65-year-old male with hepatocellular carcinoma was admitted to our hospital." | 1.29 | [A case of hepatocellular carcinoma whose lung metastases and tumor emboli in the inferior vena cava disappeared by oral administration of UFT]. ( Fujiyama, S; Hashiguchi, O; Hayashida, T; Ikebe, M; Noumaru, S; Sato, K; Sato, T; Shibata, J, 1994) |
| "A 74-year-old man was diagnosed as hepatocellular carcinoma (HCC) in the area of S6-7 with tumor thrombus continuously developed from hepatic vein to inferior vena cava (IVC)." | 1.29 | [Vanishing tumor thrombus in IVC after oral administration of UFT and TAE in a patient with HCC; a case report]. ( Ito, T; Koreeda, C; Naitoh, Y; Nakagawa, T; Okuno, H; Seki, T; Shiro, T; Tagawa, Y; Wakabayashi, M; Yamamura, H, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.26) | 18.7374 |
| 1990's | 4 (21.05) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Q | 1 |
| Zhao, JR | 1 |
| Zhang, AX | 1 |
| Li, SL | 1 |
| Neki, K | 1 |
| Kawahara, H | 2 |
| Watanabe, K | 2 |
| Toyama, Y | 2 |
| Akiba, T | 1 |
| Yanaga, K | 2 |
| Izumo, W | 1 |
| Furukawa, K | 1 |
| Katsuragawa, H | 1 |
| Komatsu, A | 1 |
| Shigematsu, K | 1 |
| Sato, S | 1 |
| Nagai, E | 1 |
| Taki, Y | 1 |
| Watanabe, M | 1 |
| Takahashi, M | 1 |
| Kyoden, Y | 1 |
| Ohata, K | 1 |
| Kanemoto, H | 1 |
| Oba, N | 1 |
| Taku, K | 1 |
| Suzuki, M | 1 |
| Takagi, M | 1 |
| Okubo, K | 1 |
| Uenosono, Y | 1 |
| Arigami, T | 1 |
| Mataki, Y | 1 |
| Matsushita, D | 1 |
| Yanagita, S | 1 |
| Kurahara, H | 1 |
| Sakoda, M | 1 |
| Kijima, Y | 1 |
| Maemura, K | 1 |
| Natsugoe, S | 1 |
| Hatano, H | 1 |
| Kobayashi, S | 3 |
| Nagano, H | 4 |
| Tomokuni, A | 1 |
| Tomimaru, Y | 1 |
| Murakami, M | 1 |
| Marubashi, S | 4 |
| Eguchi, H | 2 |
| Takeda, Y | 4 |
| Tanemura, M | 2 |
| Wakasa, K | 1 |
| Doki, Y | 2 |
| Mori, M | 2 |
| Matsusaka, S | 1 |
| Chìn, K | 1 |
| Ogura, M | 1 |
| Suenaga, M | 1 |
| Shinozaki, E | 1 |
| Mishima, Y | 1 |
| Terui, Y | 1 |
| Mizunuma, N | 1 |
| Hatake, K | 1 |
| Koizumi, S | 1 |
| Iwasaki, Y | 1 |
| Ohashi, M | 1 |
| Iwanaga, T | 1 |
| Ohinata, R | 1 |
| Takahashi, K | 1 |
| Yamaguchi, T | 1 |
| Matsumoto, H | 1 |
| Nakano, D | 1 |
| Tateishi, Y | 1 |
| Yamada, D | 1 |
| Wada, H | 2 |
| Umeshita, K | 3 |
| Yanagisawa, S | 1 |
| Hoshimoto, S | 1 |
| Hagiuda, J | 1 |
| Igarashi, N | 1 |
| Matsui, H | 1 |
| Koyama, Y | 1 |
| Miyakita, M | 1 |
| Takanosu, S | 1 |
| Nakamura, M | 2 |
| Sakon, M | 1 |
| Yamamoto, T | 1 |
| Ota, H | 1 |
| Yoshioka, S | 1 |
| Kato, H | 1 |
| Damdinsuren, B | 1 |
| Miyamoto, A | 2 |
| Nakamori, S | 1 |
| Dono, K | 2 |
| Monden, M | 2 |
| Hasegawa, S | 1 |
| Yoshikawa, T | 1 |
| Yoshida, T | 1 |
| Osaragi, T | 1 |
| Cho, H | 1 |
| Tsuburaya, A | 1 |
| Kobayashi, O | 1 |
| Sairenji, M | 1 |
| Shibata, J | 1 |
| Hayashida, T | 1 |
| Ikebe, M | 1 |
| Sato, K | 1 |
| Noumaru, S | 1 |
| Fujiyama, S | 1 |
| Sato, T | 1 |
| Hashiguchi, O | 1 |
| Tagawa, Y | 1 |
| Seki, T | 1 |
| Shiro, T | 1 |
| Nakagawa, T | 1 |
| Wakabayashi, M | 1 |
| Ito, T | 1 |
| Yamamura, H | 1 |
| Koreeda, C | 1 |
| Naitoh, Y | 1 |
| Okuno, H | 1 |
| Shiomi, K | 1 |
| Kamura, K | 1 |
| Seto, K | 1 |
| Hamaguchi, K | 1 |
| Matsushita, K | 1 |
| Yamauchi, T | 1 |
| Tomita, M | 1 |
| Ishikawa, H | 1 |
| Nakagoe, T | 1 |
| Shimizu, T | 1 |
| Hirano, T | 1 |
| Eida, K | 1 |
| Ishii, T | 1 |
| Tobinaga, K | 1 |
| Kotake, Y | 1 |
| Nogawa, T | 1 |
| Kikuchi, K | 1 |
| Kunii, Y | 1 |
| Kikuchi, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy[NCT05298722] | 45 participants (Anticipated) | Interventional | 2022-12-12 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for tegafur and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
[A case of advanced gastric cancer with tumor embolus in the portal vein and liver metastasis responding to S-1 plus cisplatin chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrect | 2014 |
18 other studies available for tegafur and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
[Efficacy of lobaplatin plus S-1 and the predictive value of circulating tumor cell in patients with advanced gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclobutanes; Disease Progression; Disease-Free Surv | 2018 |
Usefulness of circulating tumor cells after preliminary chemotherapy for prediction of response to further anticancer therapy in patients with initially unresectable metastatic colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protoco | 2013 |
A long-surviving case of gastric cancer with main portal vein tumor thrombus after surgical resection and postoperative S-1 therapy.
Topics: Adenocarcinoma; Aged; Chemotherapy, Adjuvant; Drug Combinations; Follow-Up Studies; Gastrectomy; Hum | 2016 |
Clinical impact of circulating tumor cells and therapy response in pancreatic cancer.
Topics: Antineoplastic Agents; Chemoradiotherapy; Deoxycytidine; Drug Combinations; Female; Gemcitabine; Hum | 2017 |
[A case of successful multimodal treatment for combined hepatocellular and cholangiocarcinoma with portal venous tumor thrombus].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2009 |
Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cisplatin; Disease-Free Sur | 2010 |
[A successfully treated case of type 4 gastric cancer with intraperitoneal free cancer cells undergoing a curative resection followed by neoadjuvant chemotherapy with S-1 plus cisplatin].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2010 |
[A long-term survival case of hepatocellular carcinoma with bone metastasis and inferior vena cava tumor thrombus successfully treated with multidisciplinary therapy].
Topics: Antimetabolites, Antineoplastic; Bone Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Thera | 2010 |
Determination of circulating tumor cells for prediction of recurrent colorectal cancer progression.
Topics: Adenocarcinoma; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Carcin | 2012 |
[A case of advanced gastric cancer with a tumor embolus in the portal vein successfully treated with TS-1 and CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug | 2004 |
[A case of HCC with inferior caval vein tumor thrombus and multiple pulmonary metastases that remarkably responded to combination therapy of TS-1 and interferon-alpha].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combine | 2005 |
[S-1 treatment against advanced HCC].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 2006 |
[A case of breast metastasis of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Signet Ring Cell; Cispl | 2007 |
[A case of hepatocellular carcinoma whose lung metastases and tumor emboli in the inferior vena cava disappeared by oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 1994 |
[Vanishing tumor thrombus in IVC after oral administration of UFT and TAE in a patient with HCC; a case report].
Topics: Aged; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinations; Embolization, Therape | 1993 |
[Tumor reduction in advanced renal cell carcinoma with tumor thrombus by renal embolization, interferon-alpha and UFT. A case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Combinations; Embo | 1997 |
[The usefulness of UFT administration in colorectal cancer with emphasis on postoperative administration (Part 3)].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Combine | 1991 |
[The problems of postoperative adjuvant chemotherapy in gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Gastrectomy; Humans; Lymphatic Metastasis; Mitomycin | 1987 |